Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
Journal of the Neurological Sciences
|
March 25, 1998
Immunomodulating therapeutic approaches for multiple sclerosis
D M Karussis, O Abramsky
Israel Journal of Medical Sciences
|
January 1, 1994
Inoculation of BCL1 lymphoma cells into CSJL/J F1 mice inhibits acute experimental autoimmune encephalomyelitis
O Abramsky, D M Karussis, R Mizrachi-Koll, et al.
Neurology
|
October 24, 2001
The effects of APOE genotype on age at onset and progression of neurodegenerative diseases
J Chapman, A D Korczyn, D M Karussis, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
March 15, 1992
Prevention of experimental autoimmune encephalomyelitis and induction of tolerance with acute immunosuppression followed by syngeneic bone marrow transplantation
D M Karussis, S Slavin, D Lehmann, et al.
Clinical and Experimental Immunology
|
April 1, 1995
Immunomodulation of autoimmunity in MRL/lpr mice with syngeneic bone marrow transplantation (SBMT)
D M Karussis, U Vourka-Karussis, D Lehmann, et al.
Neurology
|
August 1, 1996
Treatment of secondary progressive multiple sclerosis with the immunomodulator linomide: a double-blind, placebo-controlled pilot study with monthly magnetic resonance imaging evaluation
D M Karussis, Z Meiner, D Lehmann, et al.
Journal of Neuroimmunology
|
December 1, 1994
Immunomodulation of experimental autoimmune myasthenia gravis with linomide
D M Karussis, D Lehmann, T Brenner, et al.
Journal of Neuroimmunology
|
April 1, 1997
Immunomodulation of autoimmunity by linomide: inhibition of antigen presentation through down regulation of macrophage activity in the model of experimental autoimmune encephalomyelitis
D Lehmann, D M Karussis, D Fluresco, et al.
Israel Journal of Medical Sciences
|
January 1, 1995
Immunomodulation of autoimmunity by linomide
D M Karussis, D Lehmann, S Slavin, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 15, 1993
Treatment of chronic-relapsing experimental autoimmune encephalomyelitis with the synthetic immunomodulator linomide (quinoline-3-carboxamide)
D M Karussis, D Lehmann, S Slavin, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
Journal of the Neurological Sciences
|
March 25, 1998
Immunomodulating therapeutic approaches for multiple sclerosis
D M Karussis, O Abramsky
Israel Journal of Medical Sciences
|
January 1, 1994
Inoculation of BCL1 lymphoma cells into CSJL/J F1 mice inhibits acute experimental autoimmune encephalomyelitis
O Abramsky, D M Karussis, R Mizrachi-Koll, et al.
Neurology
|
October 24, 2001
The effects of APOE genotype on age at onset and progression of neurodegenerative diseases
J Chapman, A D Korczyn, D M Karussis, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
March 15, 1992
Prevention of experimental autoimmune encephalomyelitis and induction of tolerance with acute immunosuppression followed by syngeneic bone marrow transplantation
D M Karussis, S Slavin, D Lehmann, et al.
Clinical and Experimental Immunology
|
April 1, 1995
Immunomodulation of autoimmunity in MRL/lpr mice with syngeneic bone marrow transplantation (SBMT)
D M Karussis, U Vourka-Karussis, D Lehmann, et al.
Neurology
|
August 1, 1996
Treatment of secondary progressive multiple sclerosis with the immunomodulator linomide: a double-blind, placebo-controlled pilot study with monthly magnetic resonance imaging evaluation
D M Karussis, Z Meiner, D Lehmann, et al.
Journal of Neuroimmunology
|
December 1, 1994
Immunomodulation of experimental autoimmune myasthenia gravis with linomide
D M Karussis, D Lehmann, T Brenner, et al.
Journal of Neuroimmunology
|
April 1, 1997
Immunomodulation of autoimmunity by linomide: inhibition of antigen presentation through down regulation of macrophage activity in the model of experimental autoimmune encephalomyelitis
D Lehmann, D M Karussis, D Fluresco, et al.
Israel Journal of Medical Sciences
|
January 1, 1995
Immunomodulation of autoimmunity by linomide
D M Karussis, D Lehmann, S Slavin, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 15, 1993
Treatment of chronic-relapsing experimental autoimmune encephalomyelitis with the synthetic immunomodulator linomide (quinoline-3-carboxamide)
D M Karussis, D Lehmann, S Slavin, et al.
Page
of 2